AbbVie Inc. (NYSE:ABBV)

Big Pharma Short Sellers Grow More Selective

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Big Pharma Short Sellers Hike Their Bets

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, AMD, AT&T, Broadcom, Energy Transfer, Ford, Fortinet, Intel, Intelsat, Shake Shack, T-Mobile and More

Stocks have hit new highs and were looking to open mildly positive on Tuesday after stronger housing data was seen. With the Dow Jones industrials up over 28,000 and the ...
Read Full Story »

AbbVie, Cigna and Other Health Care Stocks With Recent Golden Crosses

Golden crosses and death crosses are common signals in technical analysis and refer to the relationship between short-term and long-term moving averages. The golden cross typically is seen as a ...
Read Full Story »

Big Pharma Scares Off Short Sellers

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Alphabet, AT&T, Facebook, Mastercard, Starbucks and More Major Earnings This Week

Now that the third-quarter earnings reporting season is has kicked off, many more major companies will be sharing their results in the coming weeks. Here, 24/7 Wall St. has put ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Big Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

20 Dividend Stocks for All Baby Boomers to Retire On

It may not be a secret that investors love dividends, but many retirees absolutely have no choice but to invest in strong dividend stocks that have a history of stable ...
Read Full Story »

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Allergan PLC (NYSE: AGN) finally has announced that its shareholders have voted to approve the company’s acquisition by AbbVie Inc. (NYSE: ABBV). The acquisition is expected to close in early ...
Read Full Story »

Big Pharma Sees Rising Tide in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

6 Large-Cap and Mega-Cap Stocks Where Analysts See Large Upside Potential

The week of September 28, 2019, was a volatile one due to headlines about climate change discussions, the ongoing trade war with China and a potential presidential impeachment. It happened ...
Read Full Story »

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

With the final quarter of 2019 beginning next Tuesday, many investors are taking a long hard look at their portfolios and trying to make some adjustments. While the end of ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Boston Beer, Carvana, HD Supply, Marathon Petroleum, Square, Trade Desk, Whirlpool and More

The futures traded higher Thursday morning as investors continue to try and discern exactly what the Democrats' impeachment plans are. The market had a strong reversal yesterday after President Trump ...
Read Full Story »

Short Sellers Grow More Selective in Big Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Ally, Anthem, Caterpillar, CVS, Deere, Oracle, PayPal, Rite Aid, Square, Uber, UnitedHealth and More

Stocks were indicated to open higher on Thursday, and the S&P 500 is again within 1% of its all-time high. The markets have been volatile, and it's impossible to forget ...
Read Full Story »